Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1999 Mar;54(3):223–229. doi: 10.1136/thx.54.3.223

One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density

J Hughes 1, B Conry 1, S Male 1, R Eastell 1
PMCID: PMC1745450  PMID: 10325897

Abstract

BACKGROUND—Inhaled corticosteroids are recognised as the most effective agents in the treatment of asthma. However, concerns have been expressed about the effects of high doses of inhaled corticosteroids on safety in relation to bone resorption and formation. This study measures the effects of two inhaled corticosteroids on bone markers and bone mineral density (BMD) over one year.
METHODS—A one year randomised, prospective, open parallel study comparing inhaled fluticasone propionate (FP), 500 µg twice daily in 30 patients, and budesonide (BUD), 800 µg twice daily in 29patients, delivered by metered dose inhaler and large volume spacers was performed in adults with moderate to severe asthma. Biochemical markers of bone turnover (osteocalcin, procollagen type 1 C-terminal propeptide (PICP), immunoreactive free deoxypyridinoline (iFDpd), N-terminal crosslinked telopeptides of type I collagen (NTx)), BMD at the spine and femoral neck, and serum cortisol concentrations were measured at baseline and 12 months later.
RESULTS—There were no significant differences between the inhaled steroids on bone markers of bone resorption and formation or bone mineral density. Bone mineral density of the spine increased slightly in both groups over the 12 month period. Serum osteocalcin levels increased from baseline in both treatment groups (FP 16.9%, p= 0.02; BUD 14.3%, p = 0.04). PICP did not differ significantly from baseline. Both markers of bone resorption (iFDpd, NTx) varied considerably with no significant changes after one year. There was a significant correlation in percentage change from baseline between BMD of the spine and osteocalcin at 12 months (r = 0.4,p = 0.017). Mean serum cortisol levels remained within the normal range in both groups following treatment.
CONCLUSION—There was no evidence of a decrease in BMD during 12 months of treatment with high doses of either FP or BUD. The change in spine BMD correlated with the increase in osteocalcin. Studies extending over several years are needed to establish whether these findings persist.



Full Text

The Full Text of this article is available as a PDF (115.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ali N. J., Capewell S., Ward M. J. Bone turnover during high dose inhaled corticosteroid treatment. Thorax. 1991 Mar;46(3):160–164. doi: 10.1136/thx.46.3.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barnes P. J., Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992. Am Rev Respir Dis. 1993 Oct;148(4 Pt 2):S1–26. doi: 10.1164/ajrccm/148.4_Pt_2.S1. [DOI] [PubMed] [Google Scholar]
  3. Boulet L. P., Giguère M. C., Milot J., Brown J. Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism. J Allergy Clin Immunol. 1994 Nov;94(5):796–803. doi: 10.1016/0091-6749(94)90145-7. [DOI] [PubMed] [Google Scholar]
  4. Brown P. H., Blundell G., Greening A. P., Crompton G. K. Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids? Thorax. 1990 Oct;45(10):736–739. doi: 10.1136/thx.45.10.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Compston J. E., Cooper C., Kanis J. A. Bone densitometry in clinical practice. BMJ. 1995 Jun 10;310(6993):1507–1510. doi: 10.1136/bmj.310.6993.1507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Crompton G. K. Corticosteroids and bone mass in asthma. Br Med J (Clin Res Ed) 1987 Jan 10;294(6564):123–123. doi: 10.1136/bmj.294.6564.123-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hanania N. A., Chapman K. R., Kesten S. Adverse effects of inhaled corticosteroids. Am J Med. 1995 Feb;98(2):196–208. doi: 10.1016/S0002-9343(99)80404-5. [DOI] [PubMed] [Google Scholar]
  8. Hanania N. A., Chapman K. R., Sturtridge W. C., Szalai J. P., Kesten S. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol. 1995 Nov;96(5 Pt 1):571–579. doi: 10.1016/s0091-6749(95)70254-7. [DOI] [PubMed] [Google Scholar]
  9. Harding S. M. The human pharmacology of fluticasone propionate. Respir Med. 1990 Nov;84 (Suppl A):25–29. doi: 10.1016/s0954-6111(08)80004-2. [DOI] [PubMed] [Google Scholar]
  10. Herrala J., Puolijoki H., Impivaara O., Liippo K., Tala E., Nieminen M. M. Bone mineral density in asthmatic women on high-dose inhaled beclomethasone dipropionate. Bone. 1994 Nov-Dec;15(6):621–623. doi: 10.1016/8756-3282(94)90309-3. [DOI] [PubMed] [Google Scholar]
  11. Hodsman A. B., Toogood J. H., Jennings B., Fraher L. J., Baskerville J. C. Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin. J Clin Endocrinol Metab. 1991 Mar;72(3):530–540. doi: 10.1210/jcem-72-3-530. [DOI] [PubMed] [Google Scholar]
  12. Ip M., Lam K., Yam L., Kung A., Ng M. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest. 1994 Jun;105(6):1722–1727. doi: 10.1378/chest.105.6.1722. [DOI] [PubMed] [Google Scholar]
  13. Jennings B. H., Andersson K. E., Johansson S. A. Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover. Eur J Clin Pharmacol. 1991;40(1):77–82. doi: 10.1007/BF00315143. [DOI] [PubMed] [Google Scholar]
  14. Kamada A. K., Szefler S. J., Martin R. J., Boushey H. A., Chinchilli V. M., Drazen J. M., Fish J. E., Israel E., Lazarus S. C., Lemanske R. F. Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network. Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1739–1748. doi: 10.1164/ajrccm.153.6.8665030. [DOI] [PubMed] [Google Scholar]
  15. Kerstjens H. A., Postma D. S., van Doormaal J. J., van Zanten A. K., Brand P. L., Dekhuijzen P. N., Koëter G. H. Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group. Thorax. 1994 Jul;49(7):652–656. doi: 10.1136/thx.49.7.652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lukert B. P., Raisz L. G. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med. 1990 Mar 1;112(5):352–364. doi: 10.7326/0003-4819-112-5-352. [DOI] [PubMed] [Google Scholar]
  17. Marystone J. F., Barrett-Connor E. L., Morton D. J. Inhaled and oral corticosteroids: their effects on bone mineral density in older adults. Am J Public Health. 1995 Dec;85(12):1693–1695. doi: 10.2105/ajph.85.12.1693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mazess R., Collick B., Trempe J., Barden H., Hanson J. Performance evaluation of a dual-energy x-ray bone densitometer. Calcif Tissue Int. 1989 Mar;44(3):228–232. doi: 10.1007/BF02556569. [DOI] [PubMed] [Google Scholar]
  19. Meeran K., Hattersley A., Burrin J., Shiner R., Ibbertson K. Oral and inhaled corticosteroids reduce bone formation as shown by plasma osteocalcin levels. Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):333–336. doi: 10.1164/ajrccm.151.2.7842187. [DOI] [PubMed] [Google Scholar]
  20. Packe G. E., Douglas J. G., McDonald A. F., Robins S. P., Reid D. M. Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. Thorax. 1992 Jun;47(6):414–417. doi: 10.1136/thx.47.6.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Packe G. E., Robb O., Robins S. P., Reid D. M., Douglas J. G. Bone density in asthmatic patients taking inhaled corticosteroids: comparison of budesonide and beclomethasone dipropionate. J R Coll Physicians Lond. 1996 Mar-Apr;30(2):128–132. [PMC free article] [PubMed] [Google Scholar]
  22. Pauwels R. A., Yernault J. C., Demedts M. G., Geusens P. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group. Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):827–832. doi: 10.1164/ajrccm.157.3.9610009. [DOI] [PubMed] [Google Scholar]
  23. Peel N., Eastell R. ABC of rheumatology. Osteoporosis. BMJ. 1995 Apr 15;310(6985):989–992. doi: 10.1136/bmj.310.6985.989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pocock N. A., Eisman J. A., Dunstan C. R., Evans R. A., Thomas D. H., Huq N. L. Recovery from steroid-induced osteoporosis. Ann Intern Med. 1987 Sep;107(3):319–323. doi: 10.7326/0003-4819-107-2-319. [DOI] [PubMed] [Google Scholar]
  25. Reid D. M., Nicoll J. J., Smith M. A., Higgins B., Tothill P., Nuki G. Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J (Clin Res Ed) 1986 Dec 6;293(6560):1463–1466. doi: 10.1136/bmj.293.6560.1463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Toogood J. H., Baskerville J. C., Markov A. E., Hodsman A. B., Fraher L. J., Jennings B., Haddad R. G., Drost D. Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma. J Allergy Clin Immunol. 1995 Aug;96(2):157–166. doi: 10.1016/s0091-6749(95)70003-x. [DOI] [PubMed] [Google Scholar]
  27. Toogood J. H., Crilly R. G., Jones G., Nadeau J., Wells G. A. Effect of high-dose inhaled budesonide on calcium and phosphate metabolism and the risk of osteoporosis. Am Rev Respir Dis. 1988 Jul;138(1):57–61. doi: 10.1164/ajrccm/138.1.57. [DOI] [PubMed] [Google Scholar]
  28. Toogood J. H., Hodsman A. B. Effects of inhaled and oral corticosteroids on bone. Ann Allergy. 1991 Aug;67(2 Pt 1):87–90. [PubMed] [Google Scholar]
  29. Toogood J. H., Jennings B., Hodsman A. B., Baskerville J., Fraher L. J. Effects of dose and dosing schedule of inhaled budesonide on bone turnover. J Allergy Clin Immunol. 1991 Oct;88(4):572–580. doi: 10.1016/0091-6749(91)90150-m. [DOI] [PubMed] [Google Scholar]
  30. Ward M. J. Inhaled corticosteroids--effect on bone? Respir Med. 1993 Feb;87 (Suppl A):33–36. doi: 10.1016/s0954-6111(05)80255-0. [DOI] [PubMed] [Google Scholar]
  31. Wolff A. H., Adelsberg B., Aloia J., Zitt M. Effect of inhaled corticosteroid on bone density in asthmatic patients: a pilot study. Ann Allergy. 1991 Aug;67(2 Pt 1):117–121. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES